Allen Institute launches atlas-to-therapy push in neurodegeneration

After more than a decade mapping the human brain at cellular resolution, the Allen Institute is launching a translational accelerator to turn those atlases into targets, biomarkers and cell-type-specific therapies for neurodegenerative diseases.

The Brain Health Accelerator (BHA) is launching with $400 million, including $200 million from the Allen Institute, $100 million from the Bezos family, and $100 million from AWS, NIH and EverythingALS. ...